| Z11 | Encounter for screening for infectious and parasitic diseases |
| Z11.0 | Encounter for screening for intestinal infectious diseases |
| Z11.1 | Encounter for screening for respiratory tuberculosis |
| Z11.2 | Encounter for screening for other bacterial diseases |
| Z11.3 | Encounter for screening for infections with a predominantly sexual mode of transmission |
| Z11.4 | Encounter for screening for human immunodeficiency virus [HIV] |
| Z11.5 | Encounter for screening for other viral diseases |
| Z11.51 | Encounter for screening for human papillomavirus (HPV) |
| Z11.52 | Encounter for screening for COVID-19 |
| Z11.59 | Encounter for screening for other viral diseases |
| Z11.6 | Encounter for screening for other protozoal diseases and helminthiases |
| Z11.7 | Encounter for testing for latent tuberculosis infection |
| Z11.8 | Encounter for screening for other infectious and parasitic diseases |
| Z11.9 | Encounter for screening for infectious and parasitic diseases, unspecified |
| Z12 | Encounter for screening for malignant neoplasms |
| Z12.0 | Encounter for screening for malignant neoplasm of stomach |
| Z12.1 | Encounter for screening for malignant neoplasm of intestinal tract |
| Z12.10 | Encounter for screening for malignant neoplasm of intestinal tract, unspecified |
| Z12.11 | Encounter for screening for malignant neoplasm of colon |
| Z12.12 | Encounter for screening for malignant neoplasm of rectum |
| Z12.13 | Encounter for screening for malignant neoplasm of small intestine |
| Z12.2 | Encounter for screening for malignant neoplasm of respiratory organs |
| Z12.3 | Encounter for screening for malignant neoplasm of breast |
| Z12.31 | Encounter for screening mammogram for malignant neoplasm of breast |
| Z12.39 | Encounter for other screening for malignant neoplasm of breast |
| Z12.4 | Encounter for screening for malignant neoplasm of cervix |
| Z12.5 | Encounter for screening for malignant neoplasm of prostate |
| Z12.6 | Encounter for screening for malignant neoplasm of bladder |
| Z12.7 | Encounter for screening for malignant neoplasm of other genitourinary organs |
| Z12.71 | Encounter for screening for malignant neoplasm of testis |
| Z12.72 | Encounter for screening for malignant neoplasm of vagina |
| Z12.73 | Encounter for screening for malignant neoplasm of ovary |
| Z12.79 | Encounter for screening for malignant neoplasm of other genitourinary organs |
| Z12.8 | Encounter for screening for malignant neoplasm of other sites |
| Z12.81 | Encounter for screening for malignant neoplasm of oral cavity |
| Z12.82 | Encounter for screening for malignant neoplasm of nervous system |
| Z12.83 | Encounter for screening for malignant neoplasm of skin |
| Z12.89 | Encounter for screening for malignant neoplasm of other sites |
| Z12.9 | Encounter for screening for malignant neoplasm, site unspecified |
| Z13 | Encounter for screening for other diseases and disorders |
| Z13.0 | Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
| Z13.1 | Encounter for screening for diabetes mellitus |
| Z13.2 | Encounter for screening for nutritional, metabolic and other endocrine disorders |
| Z13.21 | Encounter for screening for nutritional disorder |
| Z13.22 | Encounter for screening for metabolic disorder |
| Z13.220 | Encounter for screening for lipoid disorders |
| Z13.228 | Encounter for screening for other metabolic disorders |
| Z13.29 | Encounter for screening for other suspected endocrine disorder |
| Z13.3 | Encounter for screening examination for mental health and behavioral disorders |
| Z13.30 | Encounter for screening examination for mental health and behavioral disorders, unspecified |
| Z13.31 | Encounter for screening for depression |
| Z13.32 | Encounter for screening for maternal depression |
| Z13.39 | Encounter for screening examination for other mental health and behavioral disorders |
| Z13.4 | Encounter for screening for certain developmental disorders in childhood |
| Z13.40 | Encounter for screening for unspecified developmental delays |
| Z13.41 | Encounter for autism screening |
| Z13.42 | Encounter for screening for global developmental delays (milestones) |
| Z13.49 | Encounter for screening for other developmental delays |
| Z13.5 | Encounter for screening for eye and ear disorders |
| Z13.6 | Encounter for screening for cardiovascular disorders |
| Z13.7 | Encounter for screening for genetic and chromosomal anomalies |
| Z13.71 | Encounter for nonprocreative screening for genetic disease carrier status |
| Z13.79 | Encounter for other screening for genetic and chromosomal anomalies |
| Z13.8 | Encounter for screening for other specified diseases and disorders |
| Z13.81 | Encounter for screening for digestive system disorders |
| Z13.810 | Encounter for screening for upper gastrointestinal disorder |
| Z13.811 | Encounter for screening for lower gastrointestinal disorder |
| Z13.818 | Encounter for screening for other digestive system disorders |
| Z13.82 | Encounter for screening for musculoskeletal disorder |
| Z13.820 | Encounter for screening for osteoporosis |
| Z13.828 | Encounter for screening for other musculoskeletal disorder |
| Z13.83 | Encounter for screening for respiratory disorder NEC |
| Z13.84 | Encounter for screening for dental disorders |
| Z13.85 | Encounter for screening for nervous system disorders |
| Z13.850 | Encounter for screening for traumatic brain injury |
| Z13.858 | Encounter for screening for other nervous system disorders |
| Z13.88 | Encounter for screening for disorder due to exposure to contaminants |
| Z13.89 | Encounter for screening for other disorder |
| Z13.9 | Encounter for screening, unspecified |
| Z14 | Genetic carrier |
| Z14.0 | Hemophilia A carrier |
| Z14.01 | Asymptomatic hemophilia A carrier |
| Z14.02 | Symptomatic hemophilia A carrier |
| Z14.1 | Cystic fibrosis carrier |
| Z14.8 | Genetic carrier of other disease |
| Z15 | Genetic susceptibility to disease |
| Z15.0 | Genetic susceptibility to malignant neoplasm |
| Z15.01 | Genetic susceptibility to malignant neoplasm of breast |
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary |
| Z15.03 | Genetic susceptibility to malignant neoplasm of prostate |
| Z15.04 | Genetic susceptibility to malignant neoplasm of endometrium |
| Z15.09 | Genetic susceptibility to other malignant neoplasm |
| Z15.8 | Genetic susceptibility to other disease |
| Z15.81 | Genetic susceptibility to multiple endocrine neoplasia [MEN] |
| Z15.89 | Genetic susceptibility to other disease |
| Z16 | Resistance to antimicrobial drugs |
| Z16.1 | Resistance to beta lactam antibiotics |
| Z16.10 | Resistance to unspecified beta lactam antibiotics |
| Z16.11 | Resistance to penicillins |
| Z16.12 | Extended spectrum beta lactamase (ESBL) resistance |
| Z16.19 | Resistance to other specified beta lactam antibiotics |
| Z16.2 | Resistance to other antibiotics |
| Z16.20 | Resistance to unspecified antibiotic |
| Z16.21 | Resistance to vancomycin |
| Z16.22 | Resistance to vancomycin related antibiotics |
| Z16.23 | Resistance to quinolones and fluoroquinolones |
| Z16.24 | Resistance to multiple antibiotics |
| Z16.29 | Resistance to other single specified antibiotic |
| Z16.3 | Resistance to other antimicrobial drugs |
| Z16.30 | Resistance to unspecified antimicrobial drugs |
| Z16.31 | Resistance to antiparasitic drug(s) |
| Z16.32 | Resistance to antifungal drug(s) |
| Z16.33 | Resistance to antiviral drug(s) |
| Z16.34 | Resistance to antimycobacterial drug(s) |
| Z16.341 | Resistance to single antimycobacterial drug |
| Z16.342 | Resistance to multiple antimycobacterial drugs |
| Z16.35 | Resistance to multiple antimicrobial drugs |
| Z16.39 | Resistance to other specified antimicrobial drug |
| Z17 | Estrogen receptor status |
| Z17.0 | Estrogen receptor positive status [ER+] |
| Z17.1 | Estrogen receptor negative status [ER-] |
| Z18 | Retained foreign body fragments |
| Z18.0 | Retained radioactive fragments |
| Z18.01 | Retained depleted uranium fragments |
| Z18.09 | Other retained radioactive fragments |
| Z18.1 | Retained metal fragments |
| Z18.10 | Retained metal fragments, unspecified |
| Z18.11 | Retained magnetic metal fragments |
| Z18.12 | Retained nonmagnetic metal fragments |
| Z18.2 | Retained plastic fragments |
| Z18.3 | Retained organic fragments |
| Z18.31 | Retained animal quills or spines |
| Z18.32 | Retained tooth |
| Z18.33 | Retained wood fragments |
| Z18.39 | Other retained organic fragments |
| Z18.8 | Other specified retained foreign body |
| Z18.81 | Retained glass fragments |
| Z18.83 | Retained stone or crystalline fragments |
| Z18.89 | Other specified retained foreign body fragments |
| Z18.9 | Retained foreign body fragments, unspecified material |
| Z19 | Hormone sensitivity malignancy status |
| Z19.1 | Hormone sensitive malignancy status |
| Z19.2 | Hormone resistant malignancy status |